Evidence map›Paper›PMID 32699836›Full record

ArticleACS applied polymer materials2020

A Regenerative Polymer Blend Composed of Glycylglycine ethyl ester-substituted Polyphosphazene and Poly (lactic-co-glycolic acid).

Kenneth S Ogueri, Kennedy S Ogueri, Harry R Allcock, Cato T Laurencin

Open access · greenAbstract read
In one paragraph

Article in ACS applied polymer materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Biomedical applications of polyphosphazenes.Medical devices & sensors · 2020
    Article
  10. Polyphosphazene polymers: The next generation of biomaterials for regenerative engineering and therapeutic drug delivery.Journal of vacuum science and technology. B, Nanotechnology & microelectronics : materials, processing, measurement, & phenomena : JVST B · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kenneth S OgueriDepartment of Materials Science and Engineering, University of Connecticut, Storrs, CT 06269, USA.ORCID 0000-0002-9529-6259
Kennedy S OgueriDepartment of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0000-0002-3847-8988
Harry R AllcockDepartment of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0000-0002-8822-3457
Cato T LaurencinDepartment of Materials Science and Engineering, University of Connecticut, Storrs, CT 06269, USA.ORCID 0000-0001-6765-3047
Pennsylvania State University · USUniversity of Connecticut · US

Funding

Regenerative Engineering of Complex Musculoskeletal Tissues and JointsDP1AR068147 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2014 to 2018
$4.1M
NIAMS NIH HHS DP1 AR068147
6 · The paper itself

Abstract

In the pursuit of continuous improvement in the area of biomaterial design, blends of mixed-substituent polyphosphazenes and poly (lactic acid-glycolic acid) (PLGA) were prepared, and their morphology of phase distributions for the first time was studied. The degradation mechanism and osteocompatibility of the blends were also evaluated for their use as regenerative materials. Poly [(ethyl phenylalanato)

Indexed as

biocompatible polymersbiodegradable polymerspoly (lactic-co-glycolic acid)polymer blendspolyphosphazenesregenerative biomaterials

Identifiers

PMID32699836
PMCPMC7375693
OpenAlexW3000058066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.